Application 013025

Type
NDA
Sponsor
HOSPIRA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001THAM-EPOTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINEINJECTABLE;INJECTION370MG/VIAL;1.75GM/VIAL;36GM/VIALNoNo
002THAMTROMETHAMINEINJECTABLE;INJECTION3.6GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N013025-001THAM-EPOTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE370MG/VIAL;1.75GM/VIAL;36GM/VIALINJECTABLE / INJECTIONApproved before 1982
N013025-002THAMTROMETHAMINE18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INJECTIONAPRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N013025-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N013025-001THAM-E370MG/VIAL;1.75GM/VIAL;36GM/VIALINJECTABLE / INJECTIONApproved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N013025-002THAM18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INJECTIONRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N013025-001THAM-E370MG/VIAL;1.75GM/VIAL;36GM/VIALINJECTABLE / INJECTIONApproved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N013025-002THAM18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INJECTIONRLD, RS, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N013025-001THAM-E370MG/VIAL;1.75GM/VIAL;36GM/VIALINJECTABLE / INJECTIONApproved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N013025-002THAM18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INJECTIONRLD, RS, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N013025-001THAM-E370MG/VIAL;1.75GM/VIAL;36GM/VIALINJECTABLE / INJECTIONApproved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N013025-002THAM18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INJECTIONRLD, RS, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N013025-001THAM-E370MG/VIAL;1.75GM/VIAL;36GM/VIALINJECTABLE / INJECTIONApproved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N013025-002THAM18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INJECTIONAPRLD, RS, Approved before 1982a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N013025-002AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09N013025-002AP1c2088c7a36db…
2026-09-14 22:38:342026-08N013025-002AP184e616aacf4f…
2026-08-18 06:07:402026-07N013025-002AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N013025-002AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N013025-002AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N013025-002AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N013025-002AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N013025-002AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N013025-002AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N013025-002AP12680178bc6a6…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N013025-002AP1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
THAMTROMETHAMINEHospira, Inc.4af52118-c12b-4ad5-30bb-959848357e8a2026-05-27Warnings, Adverse reactionsExact identifier
application applno (NDA): 013025
application number: NDA013025
ndc (product): 0409-1593

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 1 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0409-1593THAMTROMETHAMINEHospira, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
350SUPPL2006-07-21
33099SUPPL2006-07-20